North America IVD Raw Materials Market Size
According to Straits Research analysis, The North America IVD Raw Materials Market was valued at USD 5696.67 Million in 2024 and is projected to reach USD 16273.9 Million by 2033, expanding at a CAGR of 12.5% during the forecast period. The primary applications driving demand include the healthcare and pharmaceutical sectors, fueled by an increasing need for disease diagnosis and therapeutic monitoring. Simultaneously, the expansion of personalized medicine is propelling the adoption of IVD raw materials. One noteworthy trend is the surge in green production and sustainability practices that contribute to market growth, as businesses focus on reducing their carbon footprint. Technological advancements in diagnostic techniques act as a significant opportunity for expansion. Moving forward, North America, particularly the U.S., is well-positioned to lead the IVD Raw Materials market, thanks to its robust healthcare infrastructure and research capabilities.
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America IVD Raw Materials Market Highlights
- By segment, Antibody was the leading Product Type in terms of market size in 2024.
- Proteins is expected to be the most lucrative Product Type segment, exhibiting the fastest growth throughout the forecast period.
- In 2024, North America contributed 34.99% to the overall global ivd raw materials market size.
- By 2033, United States is anticipated to dominate the global market based on market size.
- Canada is expected to witness the fastest growth within North America, attaining USD 132.59 Million by 2033.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope |
Details |
| Base Year for Study |
2024 |
| Study Period |
2020-2033 |
| Historical Period |
2020-2023 |
| Forecast Period |
2025-2033 |
| Market Size In 2024 |
USD 5696.67 Million |
| Market Size In 2033 |
USD 16273.9 Million |
| Largest segment |
Antibody |
| Fastest segment |
Proteins |
| Units |
Revenue in USD Million |
| CAGR |
12.5% (2025-2033) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
North America IVD Raw Materials Market Share By Product Type
Segmentation Covered
| Segments |
Sub Segments |
| Country |
- United States
- Canada
|
| Product Type |
- Antibody
- Antigens
- Proteins
- Enzymes
- Biological Buffers
- Substrates
- Others
|
| Technology |
- Molecular Diagnostics
- Clinical Chemistry
- Immunochemistry
- Other
|
| End User |
- Diagnostic Laboratories
- Pharmaceutical & Biotechnological Companies
- Others
|
North America IVD Raw Materials Market By Country 2033
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America IVD Raw Materials Market By Product Type 2033
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America IVD Raw Materials Market By Technology 2033
Source: Straits Research Analysis Company Publications, Primary Interviews.
North America IVD Raw Materials Market By End User 2033
Source: Straits Research Analysis Company Publications, Primary Interviews.